ArticleBone marrow transplantation2022

Successful treatment of refractory pure red cell aplasia in major ABO-mismatched allogeneic hematopoietic stem cell transplant with single agent Ibrutinib.

Shukaib Arslan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.